Target intelligence / Profile preview

Gastric hydrochloric acid and luminal gastric contents

Molecular classification
Inorganic compound, Biological fluid, Other
01

Overview

Gastric hydrochloric acid and luminal gastric contents represent the chemical and enzymatic environment of the stomach, primarily characterized by a low pH (1.5 to 3.5) maintained by parietal cell secretion of hydrochloric acid (HCl). This acidic environment is vital for the activation of pepsinogen into the proteolytic enzyme pepsin, the denaturation of dietary proteins, and the elimination of ingested pathogens (StatPearls, 2023). However, when the protective mucosal barrier is overwhelmed or when these contents reflux into the esophagus, they contribute to the pathogenesis of gastroesophageal reflux disease (GERD), gastritis, and peptic ulcer disease (NIH, 2022). Unlike systemic pharmacological agents that inhibit acid production by targeting receptors or enzymes, certain therapeutic classes target the luminal contents directly. Antacids act by chemically neutralizing HCl to increase gastric pH, thereby reducing mucosal irritation and pepsin activity, while alginates react with the acid to form a physical, pH-neutral barrier or raft that floats on top of the gastric contents to prevent reflux (NCBI, 2022).

Other names
Gastric acidStomach acidGastric juiceLuminal gastric acidHydrochloric acid
02

Mechanism of action

Chemical neutralization of hydrochloric acid to increase gastric pH and the formation of a physical barrier (raft) to prevent reflux of luminal contents.

03

Biological functions

DigestionProteolysisAntimicrobial defenseNutrient absorptionOther
04

Disease associations

Gastroesophageal reflux diseasePeptic ulcer diseaseGastritisDyspepsiaOther
05

Safety considerations

Milk-alkali syndromeElectrolyte imbalanceAltered drug absorptionAcid reboundIncreased risk of enteric infections
06

Interacting drugs

Calcium carbonate

5 more in the full profile.

07

Biomarkers

Gastric pHGastrin levelsPepsin activity

Beyond the preview

Go deeper on Gastric hydrochloric acid and luminal gastric contents.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric hydrochloric acid and luminal gastric contents.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call